Atlas Trials

Paolo Ghia

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Paolo Ghia

RecordFirmDate
Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens (NCT04790045)Paolo Ghia2023-11-01
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL) (NCT04758975)Paolo Ghia2022-09-19
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL (NCT04908228)Paolo Ghia2021-12-13
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT04754035)Paolo Ghia2017-11-08

Track Paolo Ghia automatically

Every clearance here is in the API, with alerts when new ones post.